Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Arcturus Bioscience, Inc. is a private company headquartered in Carlsbad, CA, that develops laser capture micro dissection instruments and reagents for the analysis of microscopic tissue samples. It was founded by Antonius P. Schuh.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Zhengzhou Yuanchuang Gene Technology Co., Ltd, established on 2016-02-03, Business scope includes collection of stem cells and immune cells,save,Preparation and technology research and development;Clinical research and transformation application of stem cells and immune cells(Operate with a valid license);Health Consulting Services(Excluding diagnosis and treatment);Biotechnology,Medical Technology Research,technology development,Technical Services,technical consulting,technology transfer;Biomedical Testing Technology Services;Somatic cell preparation quality inspection,Identification service;one type,Production and sales of Class II medical devices;mask sales(Except for national restrictions);cosmetic,Healthy food,Research and development of hygienic materials and dressings,production and sales;Biological product,Technical development and sales of medical devices(Except for national restrictions);Economic Information Consulting(stock,securities,futures,Except financial);Network technology development;Import and export of goods or technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Suzhou Yuna Medical Equipment Co., Ltd., established on 2013-07-25, Business scope includes medical devices,medical equipment,Testing Equipment,electronic product,Technology research and development of computer software and hardware,technology transfer,Technical consulting and sales of the above products;Production and sales of related medical non-hazardous chemical reagents and consumables;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) Production of Class II Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Sanarus Medical, Inc., part of Sanarus Technologies LLC, is an American company located in Pleasanton, CA, that manufactures minimally invasive medical devices. The firm was founded in 1999 by Seth A. Stabinsky and Glenn Foy. BJ Hardman is currently the CEO of the company. Sanarus Technologies LLC acquired Sanarus Medical, Inc. on July 16, 2009.\nThe company says this about itself: Sanarus Medical, Inc., is a leading developer of minimally invasive medical devices for diagnosing and treating breast disease.

GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company was founded on April 20, 2018 and is headquartered in Seoul, South Korea.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.